메뉴 건너뛰기




Volumn 1, Issue 11, 2010, Pages 737-746

Selective acetylcholinesterase inhibitor activated by acetylcholinesterase releases an active chelator with neurorescuing and anti-amyloid activities

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CARBAMIC ACID; CHELATING AGENT; CLIOQUINOL; CLORGYLINE; COPPER ION; HLA20; HLA20 A; IRON; RASAGILINE; RIVASTIGMINE; SELEGILINE; UNCLASSIFIED DRUG; ZINC ION;

EID: 78649453067     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn100069c     Document Type: Article
Times cited : (44)

References (61)
  • 3
    • 0030885482 scopus 로고    scopus 로고
    • Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
    • Smith, M. A., Harris, P. L., Sayre, L. M., and Perry, G. (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals Proc. Natl. Acad. Sci. U.S.A. 94, 9866-9868
    • (1997) Proc. Natl. Acad. Sci. U.S.A. , vol.94 , pp. 9866-9868
    • Smith, M.A.1    Harris, P.L.2    Sayre, L.M.3    Perry, G.4
  • 5
    • 34248577510 scopus 로고    scopus 로고
    • Metal specificity of an iron-responsive element in Alzheimer's APP mRNA 5′untranslated region, tolerance of SH-SY5Y and H4 neural cells to desferrioxamine, clioquinol, VK-28, and a piperazine chelator
    • Bandyopadhyay, S., Huang, X., Cho, H., Greig, N. H., Youdim, M. B., and Rogers, J. T. (2006) Metal specificity of an iron-responsive element in Alzheimer's APP mRNA 5′untranslated region, tolerance of SH-SY5Y and H4 neural cells to desferrioxamine, clioquinol, VK-28, and a piperazine chelator J. Neural Transm. Suppl. 237-247
    • (2006) J. Neural Transm. Suppl. , pp. 237-247
    • Bandyopadhyay, S.1    Huang, X.2    Cho, H.3    Greig, N.H.4    Youdim, M.B.5    Rogers, J.T.6
  • 7
    • 43049150678 scopus 로고    scopus 로고
    • Metals in Alzheimer's and Parkinson's diseases
    • Barnham, K. J. and Bush, A. I. (2008) Metals in Alzheimer's and Parkinson's diseases Curr. Opin. Chem. Biol. 12, 222-228
    • (2008) Curr. Opin. Chem. Biol. , vol.12 , pp. 222-228
    • Barnham, K.J.1    Bush, A.I.2
  • 9
    • 36749095848 scopus 로고    scopus 로고
    • Therapeutic treatment of Alzheimer's disease using metal complexing agents
    • Price, K. A., Crouch, P. J., and White, A. R. (2007) Therapeutic treatment of Alzheimer's disease using metal complexing agents Recent Pat. CNS Drug Discovery 2, 180-187
    • (2007) Recent Pat. CNS Drug Discovery , vol.2 , pp. 180-187
    • Price, K.A.1    Crouch, P.J.2    White, A.R.3
  • 10
    • 70350686620 scopus 로고    scopus 로고
    • Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease
    • Scott, L. E. and Orvig, C. (2009) Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease Chem. Rev. 109, 4885-4910
    • (2009) Chem. Rev. , vol.109 , pp. 4885-4910
    • Scott, L.E.1    Orvig, C.2
  • 12
    • 0026361443 scopus 로고
    • Clinically useful chelators of tripositive elements
    • Hider, R. C. and Hall, A. D. (1991) Clinically useful chelators of tripositive elements Prog. Med. Chem. 28, 41-173
    • (1991) Prog. Med. Chem. , vol.28 , pp. 41-173
    • Hider, R.C.1    Hall, A.D.2
  • 14
    • 0033964859 scopus 로고    scopus 로고
    • In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: A central role for bound transition metals
    • Sayre, L. M., Perry, G., Harris, P. L., Liu, Y., Schubert, K. A., and Smith, M. A. (2000) In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals J. Neurochem. 74, 270-279
    • (2000) J. Neurochem. , vol.74 , pp. 270-279
    • Sayre, L.M.1    Perry, G.2    Harris, P.L.3    Liu, Y.4    Schubert, K.A.5    Smith, M.A.6
  • 15
    • 0037462303 scopus 로고    scopus 로고
    • A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated tau of Alzheimer's disease
    • Shin, R. W., Kruck, T. P., Murayama, H., and Kitamoto, T. (2003) A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated tau of Alzheimer's disease Brain Res. 961, 139-146
    • (2003) Brain Res. , vol.961 , pp. 139-146
    • Shin, R.W.1    Kruck, T.P.2    Murayama, H.3    Kitamoto, T.4
  • 16
    • 3342879300 scopus 로고    scopus 로고
    • Molecular shuttle chelation: The use of ascorbate, desferrioxamine and Feralex-G in combination to remove nuclear bound aluminum
    • Kruck, T. P., Cui, J. G., Percy, M. E., and Lukiw, W. J. (2004) Molecular shuttle chelation: the use of ascorbate, desferrioxamine and Feralex-G in combination to remove nuclear bound aluminum Cell. Mol. Neurobiol. 24, 443-459
    • (2004) Cell. Mol. Neurobiol. , vol.24 , pp. 443-459
    • Kruck, T.P.1    Cui, J.G.2    Percy, M.E.3    Lukiw, W.J.4
  • 18
    • 2942750367 scopus 로고    scopus 로고
    • Clioquinol, a drug for Alzheimer's disease specifically interfering with brain metal metabolism: Structural characterization of its zinc(II) and copper(II) complexes
    • Di Vaira, M., Bazzicalupi, C., Orioli, P., Messori, L., Bruni, B., and Zatta, P. (2004) Clioquinol, a drug for Alzheimer's disease specifically interfering with brain metal metabolism: structural characterization of its zinc(II) and copper(II) complexes Inorg. Chem. 43, 3795-3797
    • (2004) Inorg. Chem. , vol.43 , pp. 3795-3797
    • Di Vaira, M.1    Bazzicalupi, C.2    Orioli, P.3    Messori, L.4    Bruni, B.5    Zatta, P.6
  • 19
    • 70350597464 scopus 로고    scopus 로고
    • Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited
    • Mancino, A. M., Hindo, S. S., Kochi, A., and Lim, M. H. (2009) Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited Inorg. Chem. 48, 9596-9598
    • (2009) Inorg. Chem. , vol.48 , pp. 9596-9598
    • Mancino, A.M.1    Hindo, S.S.2    Kochi, A.3    Lim, M.H.4
  • 25
    • 0024320494 scopus 로고
    • Selective neurotoxicity of clioquinol on the function of the posterior column nuclei
    • Arasaki, K. and Nakanishi, T. (1989) Selective neurotoxicity of clioquinol on the function of the posterior column nuclei Neurosci. Lett. 107, 85-88
    • (1989) Neurosci. Lett. , vol.107 , pp. 85-88
    • Arasaki, K.1    Nakanishi, T.2
  • 26
    • 67650759968 scopus 로고    scopus 로고
    • Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy
    • Zheng, H., Youdim, M. B., and Fridkin, M. (2009) Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective- neurorestorative moieties for Alzheimer's therapy J. Med. Chem. 52, 4095-4098
    • (2009) J. Med. Chem. , vol.52 , pp. 4095-4098
    • Zheng, H.1    Youdim, M.B.2    Fridkin, M.3
  • 28
    • 33749186347 scopus 로고    scopus 로고
    • A pro-chelator triggered by hydrogen peroxide inhibits iron-promoted hydroxyl radical formation
    • Charkoudian, L. K., Pham, D. M., and Franz, K. J. (2006) A pro-chelator triggered by hydrogen peroxide inhibits iron-promoted hydroxyl radical formation J. Am. Chem. Soc. 128, 12424-12425
    • (2006) J. Am. Chem. Soc. , vol.128 , pp. 12424-12425
    • Charkoudian, L.K.1    Pham, D.M.2    Franz, K.J.3
  • 29
    • 27544471828 scopus 로고    scopus 로고
    • Novel potential neuroprotective agents with both iron chelating and amino acid-based derivatives targeting central nervous system neurons
    • Zheng, H., Youdim, M. B., Weiner, L. M., and Fridkin, M. (2005) Novel potential neuroprotective agents with both iron chelating and amino acid-based derivatives targeting central nervous system neurons Biochem. Pharmacol. 70, 1642-1652
    • (2005) Biochem. Pharmacol. , vol.70 , pp. 1642-1652
    • Zheng, H.1    Youdim, M.B.2    Weiner, L.M.3    Fridkin, M.4
  • 31
    • 64049102869 scopus 로고    scopus 로고
    • Metal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's disease
    • Liu, G., Men, P., Perry, G., and Smith, M. A. (2009) Metal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's disease J. Nanoneurosci. 1, 42-55
    • (2009) J. Nanoneurosci. , vol.1 , pp. 42-55
    • Liu, G.1    Men, P.2    Perry, G.3    Smith, M.A.4
  • 32
    • 77953864734 scopus 로고    scopus 로고
    • Site-activated chelators targeting acetylcholinesterase and monoamine oxidase for Alzheimer's therapy
    • Zheng, H., Youdim, M. B., and Fridkin, M. (2010) Site-activated chelators targeting acetylcholinesterase and monoamine oxidase for Alzheimer's therapy ACS Chem. Biol. 5, 603-610
    • (2010) ACS Chem. Biol. , vol.5 , pp. 603-610
    • Zheng, H.1    Youdim, M.B.2    Fridkin, M.3
  • 33
    • 11844255676 scopus 로고    scopus 로고
    • Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases
    • Zheng, H., Weiner, L. M., Bar-Am, O., Epsztejn, S., Cabantchik, Z. I., Warshawsky, A., Youdim, M. B., and Fridkin, M. (2005) Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases Bioorg. Med. Chem. 13, 773-783
    • (2005) Bioorg. Med. Chem. , vol.13 , pp. 773-783
    • Zheng, H.1    Weiner, L.M.2    Bar-Am, O.3    Epsztejn, S.4    Cabantchik, Z.I.5    Warshawsky, A.6    Youdim, M.B.7    Fridkin, M.8
  • 34
    • 25644461154 scopus 로고    scopus 로고
    • Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: In vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition
    • DOI 10.1111/j.1471-4159.2005.03340.x
    • Zheng, H., Gal, S., Weiner, L. M., Bar-Am, O., Warshawsky, A., Fridkin, M., and Youdim, M. B. (2005) Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition J. Neurochem. 95, 68-78 (Pubitemid 41384426)
    • (2005) Journal of Neurochemistry , vol.95 , Issue.1 , pp. 68-78
    • Zheng, H.1    Gal, S.2    Weiner, L.M.3    Bar-Am, O.4    Warshawsky, A.5    Fridkin, M.6    Youdim, M.B.H.7
  • 35
    • 43249100611 scopus 로고    scopus 로고
    • Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators
    • Amit, T., Avramovich-Tirosh, Y., Youdim, M. B., and Mandel, S. (2008) Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators FASEB J. 22, 1296-1305
    • (2008) FASEB J. , vol.22 , pp. 1296-1305
    • Amit, T.1    Avramovich-Tirosh, Y.2    Youdim, M.B.3    Mandel, S.4
  • 36
    • 33845879870 scopus 로고    scopus 로고
    • Therapeutic targets and potential of the novel brain- permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease
    • Avramovich-Tirosh, Y., Amit, T., Bar-Am, O., Zheng, H., Fridkin, M., and Youdim, M. B. (2007) Therapeutic targets and potential of the novel brain- permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease J. Neurochem. 100, 490-502
    • (2007) J. Neurochem. , vol.100 , pp. 490-502
    • Avramovich-Tirosh, Y.1    Amit, T.2    Bar-Am, O.3    Zheng, H.4    Fridkin, M.5    Youdim, M.B.6
  • 37
    • 34347328257 scopus 로고    scopus 로고
    • The kinetics of inhibition of human acetylcholinesterase and butyrylcholinesterase by two series of novel carbamates
    • Groner, E., Ashani, Y., Schorer-Apelbaum, D., Sterling, J., Herzig, Y., and Weinstock, M. (2007) The kinetics of inhibition of human acetylcholinesterase and butyrylcholinesterase by two series of novel carbamates Mol. Pharmacol. 71, 1610-1617
    • (2007) Mol. Pharmacol. , vol.71 , pp. 1610-1617
    • Groner, E.1    Ashani, Y.2    Schorer-Apelbaum, D.3    Sterling, J.4    Herzig, Y.5    Weinstock, M.6
  • 38
    • 33947235192 scopus 로고    scopus 로고
    • Comparison of methods for analyzing kinetic data from mechanism-based enzyme inactivation: Application to nitric oxide synthase
    • Maurer, T. and Fung, H. L. (2000) Comparison of methods for analyzing kinetic data from mechanism-based enzyme inactivation: application to nitric oxide synthase AAPS PharmSci 2 E8
    • (2000) AAPS PharmSci , vol.2
    • Maurer, T.1    Fung, H.L.2
  • 39
    • 73649151319 scopus 로고
    • Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase
    • Kitz, R. and Wilson, I. B. (1962) Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase J. Biol. Chem. 237, 3245-3249
    • (1962) J. Biol. Chem. , vol.237 , pp. 3245-3249
    • Kitz, R.1    Wilson, I.B.2
  • 40
    • 4244058697 scopus 로고
    • Simplified experimental route for obtaining Job's curves
    • MacCarthy, P. (1978) Simplified experimental route for obtaining Job's curves Anal. Chem. 50, 2165
    • (1978) Anal. Chem. , vol.50 , pp. 2165
    • MacCarthy, P.1
  • 41
    • 0015040637 scopus 로고
    • Spectrophotometric determination of serum iron at the submicrogram level with a new reagent (ferrozine)
    • Carter, P. (1971) Spectrophotometric determination of serum iron at the submicrogram level with a new reagent (ferrozine) Anal. Biochem. 40, 450-458
    • (1971) Anal. Biochem. , vol.40 , pp. 450-458
    • Carter, P.1
  • 42
    • 0015765566 scopus 로고
    • Facilitation of Fe(II) autoxidation by Fe(3) complexing agents
    • Harris, D. C. and Aisen, P. (1973) Facilitation of Fe(II) autoxidation by Fe(3) complexing agents Biochim. Biophys. Acta 329, 156-158
    • (1973) Biochim. Biophys. Acta , vol.329 , pp. 156-158
    • Harris, D.C.1    Aisen, P.2
  • 43
    • 84984088084 scopus 로고
    • Hydroxamate Complexes. III. Iron(III) Exchange between Sideramines and Complexones. A Discussion of the Formation Constants of the Hydroxamate Complexes
    • Anderegg, G., L'Eplattenier, F., and Schwarzenbach, G. (1963) Hydroxamate Complexes. III. Iron(III) Exchange between Sideramines and Complexones. A Discussion of the Formation Constants of the Hydroxamate Complexes Helv. Chim. Acta 46, 1409-1422
    • (1963) Helv. Chim. Acta , vol.46 , pp. 1409-1422
    • Anderegg, G.1    L'Eplattenier, F.2    Schwarzenbach, G.3
  • 45
    • 84881231454 scopus 로고    scopus 로고
    • The ALOGPS 2.1 program
    • The ALOGPS 2.1 program. http://www.vcclab.org/lab/alogps/start.html.
  • 46
    • 0033985927 scopus 로고    scopus 로고
    • Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease
    • Jann, M. W. (2000) Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease Pharmacotherapy 20, 1-12
    • (2000) Pharmacotherapy , vol.20 , pp. 1-12
    • Jann, M.W.1
  • 47
    • 34547634202 scopus 로고    scopus 로고
    • IDEAL: A 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease
    • Winblad, B., Grossberg, G., Froölich, L., Farlow, M., Zechner, S., Nagel, J., and Lane, R. (2007) IDEAL: A 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease Neurology 69, S14-22
    • (2007) Neurology , vol.69 , pp. 14-22
    • Winblad, B.1    Grossberg, G.2    Froölich, L.3    Farlow, M.4    Zechner, S.5    Nagel, J.6    Lane, R.7
  • 48
    • 51249118269 scopus 로고    scopus 로고
    • Monoamine oxidase inactivation: From pathophysiology to therapeutics
    • Bortolato, M., Chen, K., and Shih, J. C. (2008) Monoamine oxidase inactivation: From pathophysiology to therapeutics Adv. Drug Delivery Rev. 60, 1527-1533
    • (2008) Adv. Drug Delivery Rev. , vol.60 , pp. 1527-1533
    • Bortolato, M.1    Chen, K.2    Shih, J.C.3
  • 49
    • 0029603541 scopus 로고
    • Failure of ketoconazole in oriental sore in India
    • Singh, S., Singh, R., and Sundar, S. (1995) Failure of ketoconazole in oriental sore in India J. Chemother. 7 (Suppl 4) 202-203
    • (1995) J. Chemother. , vol.7 , Issue.SUPPL. 4 , pp. 202-203
    • Singh, S.1    Singh, R.2    Sundar, S.3
  • 50
    • 10344249883 scopus 로고    scopus 로고
    • Metal-protein attenuating compounds and Alzheimer's disease
    • Ritchie, C. W., Bush, A. I., and Masters, C. L. (2004) Metal-protein attenuating compounds and Alzheimer's disease Expert Opin. Invest. Drugs 13, 1585-1592
    • (2004) Expert Opin. Invest. Drugs , vol.13 , pp. 1585-1592
    • Ritchie, C.W.1    Bush, A.I.2    Masters, C.L.3
  • 51
    • 33750603844 scopus 로고    scopus 로고
    • Alzheimer's centennial legacy: Prospects for rational therapeutic intervention targeting the Abeta amyloid pathway
    • Masters, C. L. and Beyreuther, K. (2006) Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway Brain 129, 2823-2839
    • (2006) Brain , vol.129 , pp. 2823-2839
    • Masters, C.L.1    Beyreuther, K.2
  • 53
    • 0021337104 scopus 로고
    • Iron-catalyzed hydroxyl radical formation. Stringent requirement for free iron coordination site
    • Graf, E., Mahoney, J. R., Bryant, R. G., and Eaton, J. W. (1984) Iron-catalyzed hydroxyl radical formation. Stringent requirement for free iron coordination site J. Biol. Chem. 259, 3620-3624
    • (1984) J. Biol. Chem. , vol.259 , pp. 3620-3624
    • Graf, E.1    Mahoney, J.R.2    Bryant, R.G.3    Eaton, J.W.4
  • 54
    • 33747889345 scopus 로고    scopus 로고
    • The effect of metal chelators on the production of hydroxyl radicals in thylakoids
    • Snyrychova, I., Pospisil, P., and Naus, J. (2006) The effect of metal chelators on the production of hydroxyl radicals in thylakoids Photosynth. Res. 88, 323-329
    • (2006) Photosynth. Res. , vol.88 , pp. 323-329
    • Snyrychova, I.1    Pospisil, P.2    Naus, J.3
  • 56
    • 0034721135 scopus 로고    scopus 로고
    • 3,5-Disubstituted-4-hydroxyphenyls linked to 3-hydroxy-2-methyl-4(1 H)-pyridinone: Potent inhibitors of lipid peroxidation and cell toxicity
    • Bebbington, D., Monck, N. J., Gaur, S., Palmer, A. M., Benwell, K., Harvey, V., Malcolm, C. S., and Porter, R. H. (2000) 3,5-Disubstituted-4- hydroxyphenyls linked to 3-hydroxy-2-methyl-4(1 H)-pyridinone: Potent inhibitors of lipid peroxidation and cell toxicity J. Med. Chem. 43, 2779-2782
    • (2000) J. Med. Chem. , vol.43 , pp. 2779-2782
    • Bebbington, D.1    Monck, N.J.2    Gaur, S.3    Palmer, A.M.4    Benwell, K.5    Harvey, V.6    Malcolm, C.S.7    Porter, R.H.8
  • 57
    • 77951607880 scopus 로고    scopus 로고
    • Antioxidant activities of curcumin and combinations of this curcuminoid with other phytochemicals
    • Aftab, N. and Vieira, A. (2010) Antioxidant activities of curcumin and combinations of this curcuminoid with other phytochemicals Phytother Res. 24, 500-502
    • (2010) Phytother Res. , vol.24 , pp. 500-502
    • Aftab, N.1    Vieira, A.2
  • 58
    • 0029449149 scopus 로고
    • Therapeutic iron chelators and their potential side-effects
    • Singh, S., Khodr, H., Taylor, M. I., and Hider, R. C. (1995) Therapeutic iron chelators and their potential side-effects Biochem. Soc. Symp. 61, 127-137
    • (1995) Biochem. Soc. Symp. , vol.61 , pp. 127-137
    • Singh, S.1    Khodr, H.2    Taylor, M.I.3    Hider, R.C.4
  • 59
    • 0035289779 scopus 로고    scopus 로고
    • Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
    • DOI 10.1016/S0169-409X(00)00129-0, PII S0169409X00001290
    • Lipinski, C. A., Lombardo, F., Dominy, B. W., and Feeney, P. J. (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Delivery Rev. 46, 3-26 (Pubitemid 33653411)
    • (2000) Advanced Drug Delivery Reviews , vol.46 , Issue.1-3 , pp. 3-26
    • Lipinski, C.A.1    Lombardo, F.2    Dominy, B.W.3    Feeney, P.J.4
  • 60
    • 0346849912 scopus 로고    scopus 로고
    • Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats
    • Shachar, D. B., Kahana, N., Kampel, V., Warshawsky, A., and Youdim, M. B. (2004) Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats Neuropharmacology 46, 254-263
    • (2004) Neuropharmacology , vol.46 , pp. 254-263
    • Shachar, D.B.1    Kahana, N.2    Kampel, V.3    Warshawsky, A.4    Youdim, M.B.5
  • 61
    • 0015040637 scopus 로고
    • Spectrophotometric determination of serum iron at the submicrogram level with a new reagent (ferrozine)
    • Carter, P. (1971) Spectrophotometric determination of serum iron at the submicrogram level with a new reagent (ferrozine) Anal. Biochem. 40, 450-458
    • (1971) Anal. Biochem. , vol.40 , pp. 450-458
    • Carter, P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.